Clinic Software
PathoGene, Inc.
About
PathoGene, Inc. is a private, seed-stage precision MedTech startup headquartered in Los Angeles, with R&D operations located in Monrovia, California. We are developing a sample-to-answer in vitro diagnostic medical device that detects and identifies all known microscopic human pathogens along with their antimicrobial resistance profiles on a single 6-hour test panel. To do this, we leverage robotic automation, third-generation DNA and RNA sequencing, and cloud computing technologies to report a molecular diagnosis to care providers and disease surveillance systems in real-time. Our goal is to deliver the necessary diagnostic tools for doctors and medical staff to make optimal treatment decisions that can ultimately improve public health as a whole, and we believe that our sample-to-answer technology can become the global standard of care for diagnosing infectious diseases.
Founders
- Joseph Mickel
- J. M. (Cofounder and Chief Visionary Officer)
Investors
News
- EIT Oxford EIT Pathogena | GenomeWeb · 2024-09-12T20:28:09.000Z
- PathGen Public Preview · 2025-12-02T09:16:37.000Z
- Pathogens.ai 2026 Company Profile: Valuation, Funding & Investors · 2024-12-03T00:00:00.000Z
- Asia PGI and partners unveil preview of PathGen: new AI-powered outbreak intelligence tool · 2025-12-01T09:10:00.000Z
- EIT Pathogena launched! – BashTheBug · 2024-10-28T17:42:57.000Z
- ABNewswire - Press Release Distribution Service: Pathogend Honored by The Philadephia Inquirer as a 2018 Stellar Startup · 2026-06-07T10:10:00.000Z
